The trademark application EVOCATH was filed by Teleflex Life Sciences Pte. Ltd., a corporation established under the laws of the Republic of Singapore (the "Applicant"). The application was published for oppositions on February 27, 2022, and it was registered by office on June 6, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).